Lv3
320 积分 2024-11-18 加入
Improved survival in advanced melanoma patients treated with fecal microbiota transplantation using healthy donor stool in combination with anti-PD1: final results of the MIMic phase 1 trial
3小时前
待确认
Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2
5小时前
已完结
TILs Outperform Ipilimumab in Melanoma
5小时前
已完结
NK Cells Mediate T-cell Inflammation in the Tumor Microenvironment
5小时前
已完结
Data from A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus–associated Epithelial Cancers
6小时前
已完结
LBA2 Updated analysis and patient-reported outcomes (PROs) from CITYSCAPE: A randomised, double-blind, phase II study of the anti-TIGIT antibody tiragolumab + atezolizumab (TA) versus placebo + atezolizumab (PA) as first-line treatment for PD-L1+ NSCLC
1天前
已完结
Hyperprogression after immunotherapy: A comprehensive review
1个月前
已关闭
Therapeutic targeting of DNA methylation alterations in cancer
1个月前
已完结
An intricate rewiring of cancer metabolism via alternative splicing
1个月前
已完结
Immunogenomic Landscape Contributes to Hyperprogressive Disease after Anti-PD-1 Immunotherapy for Cancer
1个月前
已完结
皖公网安备34019202002308
